Pharmacokinetic-pharmacodynamic assessment of the hepatic and bone marrow toxicities of the new trypanoside fexinidazole
Copyright © 2019 Watson et al. Fexinidazole is a novel oral treatment for human African trypanosomiasis caused by Trypanosoma brucei gambiense (g-HAT). Fexinidazole also has activity against T. cruzi, the causative agent of Chagas disease. During the course of a dose ranging assessment in patients w...
Saved in:
Main Authors: | James A. Watson, Nathalie Strub-Wourgraft, Antoine Tarral, Isabela Ribeiro, Joel Tarning, Nicholas J. White |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/51767 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives
by: Nicholas J. White
Published: (2018) -
Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
by: Nicholas J. White, et al.
Published: (2018) -
Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization
by: Nicholas J. White
Published: (2018) -
Pharmacokinetic and pharmacodynamic mechanisms for reduced toxicity of CPT-11 by thalidomide and St John's wort
by: YANG XIAOXIA
Published: (2010) -
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection
by: Colvin,R.A., et al.
Published: (2015)